Frontline Medical Communications and The National Organization for Rare Disorders (NORD) signed a strategic partnership agreement in 2014 to collaborate and develop innovative educational programs for healthcare providers (HCPs). Harnessing the expertise of each organization, FMC and NORD seek to improve awareness, understanding and recognition of rare diseases among HCPs to accelerate diagnosis and promote optimal care for patients. Other goals include updating HCPs on new treatment options and clinical care standards as well as facilitating the sharing of information among HCPs and rare disease medical experts. The partnership develops interactive resources and custom initiatives to meet the urgent, unmet need for HCP education on rare diseases as well as improving the lives of the 30 million Americans who suffer from nearly 7,000 rare disorders.
Frontline Medical Communications and NORD Develop Partnership | PDF
Listen to interview with NORD President/CEO Peter Saltonstall
R&D, Commercialization and Awareness of Rare Diseases | Article
For more information about NORD, please contact:
Elizabeth Katz, Group Publisher